Guanze Medical Keeps Capital Structure Steady in March; Confirms Public Float Compliance

Bulletin Express04-08

Guanze Medical Information Industry (Holding) Co., Ltd. filed its monthly return for the period ended 31 March 2026, reporting no changes to either authorised or issued share capital.

• Authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million.

• Issued share capital stayed flat at 950 million ordinary shares; the company held no treasury shares.

• The company confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25 percent of issued shares.

• No share options, warrants, convertibles, or other equity-linked instruments were granted, exercised, converted, or cancelled during the month.

• The return was submitted to Hong Kong Exchanges and Clearing Limited on 8 April 2026.

The absence of equity movements in March signals a stable capital structure for Guanze Medical as it progresses through FY26.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment